COVID-19患者卒中的病例对照分析:COVID-19不寻常表现研究11的结果
该研究回顾性分析了62家西班牙急诊科在COVID-19疫情期间诊治的所有COVID-19患者,识别出147例卒中(1.96‰),低于非COVID-19患者的4.71‰(OR=0.42)。合并卒中的COVID-19患者更多表现为意识模糊、意识下降和晕厥,D-二聚体和白细胞更高。校正年龄性别后,其住院和ICU入住率高于无卒中的COVID-19对照,住院时间和院内死亡率高于无COVID-19的卒中对照。
要点
- 急诊COVID-19患者卒中发生率为1.96‰(95%CI 1.66‰-2.31‰),低于非COVID-19患者的4.71‰(OR=0.42,95%CI 0.35-0.49)。
- COVID-19合并卒中患者更常见意识模糊、意识下降和晕厥,且D-二聚体和白细胞计数更高。
- 校正年龄性别后,COVID-19合并卒中者住院率(OR=3.41,95%CI 1.27-9.16)和ICU入住率(OR=3.79,95%CI 1.69-8.50)高于无卒中的COVID-19对照。
- 与非COVID-19卒中患者相比,COVID-19合并卒中者住院时间更长(OR=1.55,95%CI 1.24-1.94)、院内死亡率更高(OR=1.77,95%CI 1.37-2.30)。
- 高血压、糖尿病、既往脑血管病和冠心病是COVID-19患者发生卒中的相关基线因素。
适用人群与场景
- 对照A为COVID-19无卒中患者,对照B为非COVID-19卒中患者。
- 研究场景为急诊科,非院前或ICU内。
诊断标准与关键阈值
- 卒中诊断依据原文未详细说明具体标准。
- COVID-19诊断依据原文未详细说明具体标准。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- COVID-19患者出现意识模糊、意识下降或晕厥时,需警惕合并卒中。
- 急诊 arrival 时D-二聚体浓度和白细胞计数升高与COVID-19患者卒中风险相关。
研究设计与关键结果
- 研究类型:回顾性病例对照分析,纳入62家西班牙急诊科,COVID-19患者74,814例中识别147例卒中(1.96‰,95%CI 1.66‰-2.31‰),非COVID-19患者1,388,879例中卒中6,541例(4.71‰,95%CI 4.60‰-4.83‰),OR=0.42(95%CI 0.35-0.49)。
- 标准化年发病率:COVID-19患者124/10万,非COVID-19患者133/10万(OR=0.93,95%CI 0.87-0.99)。
- 与无卒中的COVID-19对照相比,校正年龄性别后,卒中组住院率OR=3.41(95%CI 1.27-9.16),ICU入住率OR=3.79(95%CI 1.69-8.50),死亡率差异无统计学意义。
- 与非COVID-19卒中对照相比,COVID-19卒中组住院时间更长(OR=1.55,95%CI 1.24-1.94),院内死亡率更高(OR=1.77,95%CI 1.37-2.30)。
证据类型、等级与局限
- 证据类型:回顾性多中心病例对照研究。
- 局限:回顾性设计、观察性研究,无法推断因果关系;卒中及COVID-19诊断标准未详述;仅纳入西班牙急诊科就诊患者,外推需谨慎。
对床旁实践的改变
- 急诊医生应认识到COVID-19患者卒中发生率虽低于非COVID-19人群,但一旦合并卒中,住院和ICU需求显著增加,需提前做好资源准备。
- 对COVID-19患者出现意识模糊、意识下降或晕厥,应警惕卒中并进行评估。
- COVID-19合并卒中患者住院时间更长、院内死亡风险更高,提示需加强监护和治疗强度。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: We investigated the incidence, predictor variables, clinical characteristics, and stroke outcomes in patients with COVID-19 seen in emergency departments (EDs) before hospitalization.
METHODS: We retrospectively reviewed all COVID-19 patients diagnosed with stroke during the COVID-19 outbreak in 62 Spanish EDs. We formed two control groups: COVID-19 patients without stroke (control A) and non-COVID-19 patients with stroke (control B). We compared disease characteristics and four outcomes between cases and controls.
RESULTS: We identified 147 strokes in 74,814 patients with COVID-19 seen in EDs (1.96‰, 95% confidence interval [CI] = 1.66‰ to 2.31‰), being lower than in non-COVID-19 patients (6,541/1,388,879, 4.71‰, 95% CI = 4.60‰ to 4.83‰; odds ratio [OR] = 0.42, 95% CI = 0.35 to 0.49). The estimated that standardized incidences of stroke per 100,000 individuals per year were 124 and 133 for COVID-19 and non-COVID-19 individuals, respectively (OR = 0.93 for COVID patients, 95% CI = 0.87 to 0.99). Baseline characteristics associated with a higher risk of stroke in COVID-19 patients were hypertension, diabetes mellitus, and previous cerebrovascular and coronary diseases. Clinically, these patients more frequently presented with confusion, decreased consciousness, and syncope and higher D-dimer concentrations and leukocyte count at ED arrival. After adjustment for age and sex, the case group had higher hospitalization and intensive care unit (ICU) admission rates (but not mortality) than COVID-19 controls without stroke (OR = 3.41, 95% CI = 1.27 to 9.16; and OR = 3.79, 95% CI = 1.69 to 8.50, respectively) and longer hospitalization and greater in-hospital mortality than stroke controls without COVID-19 (OR = 1.55, 95% CI = 1.24 to 1.94; and OR = 1.77, 95% CI = 1.37 to 2.30, respectively).
CONCLUSIONS: The incidence of stroke in COVID-19 patients presenting to EDs was lower than that in the non-COVID-19 reference sample. COVID-19 patients with stroke had greater need for hospitalization and ICU admission than those without stroke and longer hospitalization and greater in-hospital mortality than non-COVID-19 patients with stroke.
参考来源
- García-Lamberechts EJ, Miró Ò, Fragiel M, et al. A case-control analysis of stroke in COVID-19 patients: Results of unusual manifestations of COVID-19-study 11. Acad Emerg Med. 2021. PMID: 34490961. doi:10.1111/acem.14389
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。